Position in GMAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,591,179
-$1,777,046 QoQ
Shares Held
59,306
-45.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 85.99973021279466.ToString("F0")%
Shared 14.00026978720534.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vestmark Advisory Solutions, Inc. holds $60,281,695 across 32 Biotechnology names. GMAB ranks #11 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
256,779 | $12,214,977 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
550,144 | $7,052,845 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
367,153 | $5,309,032 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
176,865 | $4,214,692 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,589 | $3,172,712 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,957 | $3,106,577 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
726,986 | $2,231,847 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
6,681 | $2,152,551 |
All Filings in GMAB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,591,179 | 59,306 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,368,225 | 109,358 | Shares | Sole | 2026-02-06 | |
| 2024-12-31 | $421,240 | 20,184 | Shares | Other | 2025-02-06 | |
| 2024-09-30 | $682,128 | 27,979 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $694,693 | 27,644 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $840,770 | 28,110 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,135,287 | 35,656 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $978,777 | 27,751 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,457,113 | 38,335 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,432,387 | 37,934 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,907,057 | 44,999 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,735,630 | 54,019 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,271,690 | 39,141 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $786,806 | 21,747 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $1,154,874 | 29,193 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,344,954 | 30,777 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $846,446 | 20,731 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $469,797 | 14,310 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $771,523 | 18,975 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $646,129 | 17,649 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $520,177 | 15,349 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $325,499 | 15,361 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||